Digital biomarker‐based individualized prognosis for people at risk of dementia
Abstract Background Research investigating treatments and interventions for cognitive decline fail due to difficulties in accurately recognizing behavioral signatures in the presymptomatic stages of the disease. For this validation study, we took our previously constructed digital biomarker‐based pr...
Main Authors: | Maximilian Buegler, Robbert L. Harms, Mircea Balasa, Irene B. Meier, Themis Exarchos, Laura Rai, Rory Boyle, Adria Tort, Maha Kozori, Eutuxia Lazarou, Michaela Rampini, Carlo Cavaliere, Panagiotis Vlamos, Magda Tsolaki, Claudio Babiloni, Andrea Soricelli, Giovanni Frisoni, Raquel Sanchez‐Valle, Robert Whelan, Emilio Merlo‐Pich, Ioannis Tarnanas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
Subjects: | |
Online Access: | https://doi.org/10.1002/dad2.12073 |
Similar Items
-
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer’s disease: the Altoida large cohort study
by: Irene B. Meier, et al.
Published: (2021-06-01) -
Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression
by: Marios G. Krokidis, et al.
Published: (2021-04-01) -
EEG-Based Brain–Computer Interfaces for Communication and Rehabilitation of People with Motor Impairment: A Novel Approach of the 21st Century
by: Ioulietta Lazarou, et al.
Published: (2018-01-01) -
Wearable Devices for Assessing Function in Alzheimer's Disease: A European Public Involvement Activity About the Features and Preferences of Patients and Caregivers
by: Thanos G. Stavropoulos, et al.
Published: (2021-04-01) -
Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer’s disease progression [version 1; referees: 3 approved]
by: Ilijana Begcevic, et al.
Published: (2018-07-01)